News
The latest science and news from the Institute.
-
Study shows potential to develop brain tumour liquid biopsies
6th November 2018
Scientists are making strides in developing liquid biopsies for brain tumours by detecting tumour DNA in the fluid from around the brain and spine.
Find out more -
Stand Up To Cancer cyclists on final leg Cambridge-London
12th October 2018
The Stand Up To Cancer Cycle Challenge team called at the Cancer Research UK Cambridge Institute on the final leg of their 500-mile Glasgow-London ride.
Find out more -
Finding meaningful patterns in complexity of ovarian cancer
13th August 2018
Patterns of genetic mutation in ovarian cancer are helping make sense of the disease and could be used to personalise treatment in future.
Find out more -
Andrew Holding receives Turing Fellowship
7th August 2018
Dr Andrew Holding has been selected to receive a fellowship grant from theĀ Alan Turing Institute.
Find out more -
Shankar Balasubramanian awarded the Royal Medal 2018
17th July 2018
Awarded the Royal Medal in recognition of the co-development of DNA sequencing techniques transforming biology and genomic medicine.
Find out more -
Antifungal drug eliminates sleeping bowel cancer cells in mice
31st May 2018
An antifungal medication, commonly prescribed for toenail infections, could help eliminate dormant cells within bowel tumours.
Find out more -
Prof Greg Hannon elected to EMBO Membership
14th May 2018
Prof Greg Hannon is among 62 outstanding life sciences researchers who have been elected as new members.
Find out more -
Institute Director elected as a Fellow of the Royal Society
9th May 2018
Institute Director, Prof Greg Hannon is among the new Fellows announced today by the Royal Society and chosen for their outstanding contributions to science.
Find out more -
Patients to benefit from new brain cancer research funding boost
22nd February 2018
Brain tumour research in the UK is set to be revolutionised with Ā£45 million in funding by the Department of Health and Social Care and Cancer Research UK.
Find out more